BIS holdings — ProShares UltraShort Nasdaq Biotechnology
ProShares UltraShort Nasdaq Biotechnology (BIS) held 9 positions with net assets of $2.42M as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 54.0% of the fund, led by Repurchase Agreement, Repurchase Agreement, Repurchase Agreement.
BIS top holdings
- Repurchase Agreement — 40.64% ($984K)
- Repurchase Agreement — 25.57% ($619K)
- Repurchase Agreement — 19.18% ($464K)
- Repurchase Agreement — 14.06% ($341K)
- N/A — -3.64% (−$88.1K)
- N/A — -3.75% (−$90.8K)
- N/A — -10.52% (−$255K)
- N/A — -11.12% (−$269K)
- N/A — -16.39% (−$397K)
What are BIS's top 10 holdings?
Repurchase Agreement (40.6%), Repurchase Agreement (25.6%), Repurchase Agreement (19.2%), Repurchase Agreement (14.1%), N/A (-3.6%), N/A (-3.7%), N/A (-10.5%), N/A (-11.1%), N/A (-16.4%).
How many stocks are in BIS?
ProShares UltraShort Nasdaq Biotechnology reported 9 holdings as of May 31, 2026.